Disclosures for "Absorption, Distribution, Metabolism, And Excretion (ADME) And Pharmacokinetic (PK) Properties of SPV-400, a Novel Tropomyosin Kinase Receptor B (TrkB) Activator"
-
An immediate family member of Dr. Choi has received personal compensation for serving as an employee of TG therapeutics, Inc. An immediate family member of Dr. Choi has received personal compensation for serving as an employee of Thermo Fisher Scientific. Dr. Choi has received personal compensation for serving as an employee of Spave Science Inc. Dr. Choi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerecin Inc. Dr. Choi has stock in Spave Science Inc. An immediate family member of Dr. Choi has stock in TG therapeutics, Inc. An immediate family member of Dr. Choi has stock in Thermo Fisher Scientific. An immediate family member of Dr. Choi has stock in Teladoc Health.
-
Dr. Renger has received personal compensation for serving as an employee of Cerevel. Dr. Renger has received personal compensation for serving as an employee of Neurtuitive LLC. Dr. Renger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurtuitive LLC. Dr. Renger has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Libra. Dr. Renger has stock in ABBV.
-
Prof. Iuvone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spave Science Inc. Prof. Iuvone has received personal compensation in the range of $0-$499 for serving as a Consultant for NeuroRays LLC. Prof. Iuvone has stock in NeuroRays LLC. The institution of Prof. Iuvone has received research support from NIH.